Statement Of Income

TAKARA BIO INC. - Filing #7300711

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Statement of income
Statement of income
Operating revenue
Net sales
Net sales
19,758,000,000 JPY
19,116,000,000 JPY
Operating expenses
Cost of sales
Cost of sales
7,313,000,000 JPY
5,772,000,000 JPY
Selling, general and administrative expenses
12,028,000,000 JPY
11,933,000,000 JPY
Other
4,390,000,000 JPY
4,260,000,000 JPY
Operating expenses
Research and development expenses
3,481,000,000 JPY
4,241,000,000 JPY
Operating profit (loss)
417,000,000 JPY
1,410,000,000 JPY
Gross profit (loss)
12,445,000,000 JPY
13,343,000,000 JPY
Ordinary profit (loss)
549,000,000 JPY
1,598,000,000 JPY
Non-operating income
Interest income
149,000,000 JPY
84,000,000 JPY
Gross profit
Extraordinary income
2,000,000 JPY
1,000,000 JPY
Non-operating expenses
Interest expenses
10,000,000 JPY
12,000,000 JPY
Selling, general and administrative expenses
Non-operating expenses
Non-operating income
Non-operating income
290,000,000 JPY
248,000,000 JPY
Financial revenue
Other
60,000,000 JPY
11,000,000 JPY
Non-operating expenses
Non-operating expenses
158,000,000 JPY
59,000,000 JPY
Financial expenses
Other
26,000,000 JPY
11,000,000 JPY
Extraordinary losses
124,000,000 JPY
12,000,000 JPY
Impairment losses
108,000,000 JPY
JPY
Other
1,000,000 JPY
JPY
Profit (loss) before income taxes
427,000,000 JPY
1,588,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
2,000,000 JPY
1,000,000 JPY
Income taxes - current
467,000,000 JPY
684,000,000 JPY
Extraordinary losses
Income taxes - deferred
-571,000,000 JPY
-195,000,000 JPY
Income taxes
-104,000,000 JPY
489,000,000 JPY
Profit (loss)
531,000,000 JPY
1,099,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.